The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity

Abstract
No abstract available
Funding Information
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases
  • CSL Behring
  • Baxalta
  • Shire
  • Takeda Pharmaceuticals U.S.A.
  • CSL Behring Chair of Primary Immunodeficiencies
  • Onderzoeksraad, KU Leuven (C1 Grant C16/18/007)
  • GC Europe (VIB GC PID Grant)
  • Research Foundation - Flanders (G0C8517N, G0B5120N, G0E8420N)
  • Jeffrey Modell Foundation
  • H2020 European Research Council (948959)
  • ERN-RITA